E. Tan

First name
E.
Middle name
H.
Last name
Tan
Barclay, N. L., Burkard, T., Burn, E., Delmestri, A., Dominguez, M., Golozar, A., et al. (2024). The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis. Clin Epidemiol, 16, 417-429. http://doi.org/10.2147/clep.s463160
Tan, E. H., Rathod-Mistry, T., . Y. Strauss, V., O'Kelly, J., Giorgianni, F., Baxter, R., et al. (2024). Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases. J Bone Miner Res. http://doi.org/10.1093/jbmr/zjae059
Jödicke, A. M., Tan, E. H., Robinson, D. E., Delmestri, A., & Prieto-Alhambra, D. (2023). Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom. Age Ageing, 52. http://doi.org/10.1093/ageing/afad177
Tan, E. H., Robinson, D. E., Jödicke, A. M., Mosseveld, M., Bødkergaard, K., Reyes, C., et al. (2023). Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporos Int. http://doi.org/10.1007/s00198-023-06837-0